Successful Treatment of Persistent Chylopericardium With Somatostatin After Operation on Ascending Aorta
| Autor: | Saziye Karaca, Afksendiyos Kalangos, Olivier Rager |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
Pulmonary and Respiratory Medicine Somatostatin/therapeutic use medicine.medical_specialty Chyle medicine.medical_treatment ddc:616.0757 Pericardial Effusion Pericardial Effusion/drug therapy Aortic aneurysm Postoperative Complications medicine.artery Ascending aorta medicine Humans Aortic rupture Aorta Aortic Aneurysm Thoracic ddc:617 Aortic Aneurysm Thoracic/surgery business.industry Remission Induction Middle Aged medicine.disease Surgery Aortic valvuloplasty Postoperative Complications/drug therapy Somatostatin Aorta/surgery Chylopericardium Tamponade Cardiology and Cardiovascular Medicine business |
| Zdroj: | Annals of Thoracic Surgery, Vol. 97, No 4 (2014) pp. e97-9 |
| ISSN: | 0003-4975 |
| DOI: | 10.1016/j.athoracsur.2013.11.078 |
| Popis: | Chylopericardium after intrathoracic surgical procedures rarely occurs. Optimal guidelines for the management of chylopericardium are lacking. In this case report, we describe our experience in treating chylopericadium with somatostatin in a 47-year-old man who underwent replacement of the ascending aorta and aortic valvuloplasty after aortic rupture. Postoperatively, a late tamponade was drained, and microbiologic analyses confirmed chyle. Conservative treatment including total parental nutrition failed, so we initiated somatostatin treatment as a continuous perfusion, with good results. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|